Skip to main content

Author: Tom Wilemon

Early-onset CRC germline genetic differences identified by race, ethnicity

Jun. 15, 2023—A Vanderbilt study that delved into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants.

Read more


Enhanced treatment helps fast nicotine metabolizers quit smoking

Jun. 8, 2023—A study from Vanderbilt researchers has found that enhanced treatment support can help smokers who have more difficulty quitting because they are fast metabolizers of nicotine.

Read more


Study discovers that tumor mutation burden predicts survival outcome

Jun. 5, 2023—The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

Read more


Liquid biopsy test may detect early-stage and low DNA-shedding cancers

May. 31, 2023—Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.

Read more


Lovly elected to American Association for Cancer Research board

May. 11, 2023—Christine Lovly, MD, PhD, has been elected to the American Association for Cancer Research board of directors.

Read more


Genomic analysis of SCLC tumors reveals subtypes, offers cues toward personalized treatments

May. 11, 2023—The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer.

Read more


Trial combines novel therapies for head and neck cancer

Apr. 27, 2023—Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.

Read more


VICC Scientific Retreat focuses on emerging technologies

Apr. 26, 2023—The Vanderbilt-Ingram Cancer Center 24th Annual Scientific Retreat will be held from 8:30 am to 3 pm, May 23, in the Vanderbilt Student Life Center.

Read more


National Cancer Institute honors Berlin’s contributions, leadership

Apr. 6, 2023—Vanderbilt's Jordan Berlin, MD, is a 2022 recipient of the National Cancer Institute Director’s Award.

Read more


New treatment helps mitigate hair loss for chemotherapy patients

Mar. 30, 2023—Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.

Read more


Sandler named co-chair of ACR’s Lung Cancer Screening Steering Committee

Mar. 30, 2023—Vanderbilt's Kim Sandler, MD, has been named co-chair of the Lung Cancer Screening Steering Committee for the American College of Radiology.

Read more


Soothing sounds

Mar. 16, 2023—Nashville pianist Ed Bazel, founder of The River of Calm music channel, recently played for patients in the waiting room of the Henry-Joyce Cancer Clinic at Vanderbilt-Ingram Cancer Center.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more